Abstract
The excellent contrast resolution obtained with MRI makes it useful for determining the anatomic extent of malignant lesions of bone and soft tissue and for assessing the degree of marrow invasion by bone sarcomas (1–16). However, MRI lacks diagnostic specificity; that is to say, the appearance of malignant lesions of bone and soft tissue, in both T1- and T2- weighted images, is often very similar to that of benign tumors, hemangiomas, and infections (6,7,14,16–18). Our experience in over 100 cases confirms this impression. In the study reviewed here, we asked the question whether or not the diagnostic specificity of an MR study could be increased by combining 31P MRS with the MRI. The rationale is based on the observations, made in a number of animal and human cancers (reviewed in references 19–24), that cancers frequently have characteristic 31P MR spectra. These characteristics include a high phosphomonoester (PME) peak, a high phosphodiester (PDE) peak, and a low phosphocreatine (PCr) peak. A high PME peak has been observed in several cases of bone and soft tissue cancers in man (25–31).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zimmer WD, Berquist TH, McLeod RA et al: Bone tumors: Magnetic resonance imaging versus computed tomography. Radiology 155:709–718, 1985.
Weekes RG, Berquist TH, McLeod RA, Zimmer WD: Magnetic resonance imaging of soft-tissue tumors: Comparison with computed tomography. Magn. Reson. Imaging 3:345–352, 1985.
Hudson TM, Hamlin DJ, Enneking WF, Pettersson H: Magnetic resonance imaging of bone and soft tissue tumors: Early experience in 31 patients compared with computed tomography. Skeletal Radiol. 13:134–146, 1985.
Bloem JL, Falke THM, Taminiau AHM et al: Magnetic resonance imaging of primary malignant bone tumors. Radiographics 5:853–886, 1986.
Aisen AM, Martel W, Braunstein EM et al: MRI and CT evaluation of primary bone and soft-tissue tumors. AJR 146:749–756, 1986.
Petasnick JP, Turner DA, Charters JR et al: Soft-tissue masses of the Locomotor system: Comparison of MR imaging with CT. Radiology 160:125–133, 1986.
Totty WG, Murphy WA, Lee JKT: Soft-tissue tumors: MR imaging. Radiology 160:135–141, 1986.
Richardson ML: Magnetic resonance imaging of musculoskeletal neoplasms. In: Magnetic Resonance in Cancer, PS Allen, DPJ Boisvert, BC Lentie (eds), Pergamon Press, New York, pp. 21–36, 1986.
Andrew ER, Pettersson HTA: MRI in the preoperative evaluation of musculoskeletal tumors. In: Magnetic Resonance in Cancer, PS Allen, DPJ Boisvert, BC Lentie (eds), Pergamon Press, New York, pp. 37–38, 1986.
Chang AE, Matory YL, Dwyer AJ et al: Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities. Ann. Surg. 205:340–348, 1987.
Bland KI, McCoy DM, Kinard RE, Copeland EM III: Application of magnetic resonance imaging and computerized tomography as an adjunct to the surgical management of soft tissue sarcomas. Ann. Surg. 205:473–481, 1987.
Boyko OB, Cory DA, Cohen MD et al: MR imaging of osteogenic and Ewing’s sarcoma. AJR 148:317–322, 1987.
Herman SD, Mesgarzadeh M, Bonakdarpour A, Dalinka MK: The role of magnetic resonance imaging in giant cell tumor of bone. Skeletal Radiol. 16:635–643, 1987.
Sundaram M, McGuire MH, Herbold DR: Magnetic resonance imaging of soft tissue masses: An evaluation of fifty-three histologically proven tumors. Magn. Reson. Imaging 6:237–248, 1988.
Haggar AM, Froelich JW: MR imaging strategies in primary and metastatic malignancy. Radiol. Clin. North Am. 26:689–696, 1988.
Pettersson H, Slone RM, Spanier S et al: Musculoskeletal tumors: T1 and T2 relaxation times. Radiology 167:783–785, 1988.
Beltran J, Simon DC, Katz W, Weis LD: Increased MR signal intensity in skeletal muscle adjacent to malignant tumors: Pathologic correlation and clinical relevance. Radiology 162:251–255, 1988.
Bloem HL, Falke THM, Doornbos J: Osteomyelitis in children: Detection by magnetic resonance. Radiology 150:57–60, 1984.
Evanochko WT, Ng TC, Glickson JD: Application of in vivo NMR spectroscopy to cancer. Magn. Reson. Medicine 1:508–534, 1984.
Sostman HD, Armitage IM, Fischer JJ: NMR in cancer. I. High resolution spectroscopy of tumors. Magn. Reson. Imaging 2:265–278, 1984.
Maris JM, Chance B: Magnetic resonance spectroscopy of neoplasms. In: Magnetic Resonance Annual, HY Kressel (ed), Raven Press, New York, pp. 213–235, 1986.
Glickson JD, Evanochko WT, Sakai TT, Ng TC: In vivo NMR spectroscopy of tumors. In: NMR Spectroscopy of Cells and Organisms, Vol. 1, RK Gupta (ed), CRC Press, Boca Raton, pp. 99–134, 1987.
Weiner MW: The promise of magnetic resonance spectroscopy for medical diagnosis. Invest. Radiol. 23:253–261, 1988.
Bottomley PA: Human in vivo NMR spectroscopy in diagnostic medicine: Clinical tool or research probe? Radiology 170:1–15, 1989.
Griffiths JR, Cady E, Edwards RHT et al: 31P-NMR studies of human tumours in situ. Lancet I:1435–1436, 1983.
Nidecker AC, Muller S, Aue WP et al: Extremity bone tumors: Evaluation by P-31 MR spectroscopy. Radiology 157:167–174, 1985.
Ng TC, Majors AW, Meany TF: In vivo MR spectroscopy of human subjects with a 1.4-T whole-body MR imager. Radiology 158:517–520, 1986.
Oberhaensli RD, Bore PJ, Rampiing RP et al: Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonace spectroscopy. Lancet 11:8–11, 1986.
Ross B, Helsper JT, Cox IJ et al: Osteosarcoma and other neoplasms of bone. Arch. Surg. 122:1464–1469, 1987.
Ng TC, Vijayakumar S, Majors AW et al: Response of a non-Hodgkin lymphoma to 60Co therapy monitored by 31MRS in situ. Int. J. Radiat. Oncol. Biol. Phys. 13:1545–1551, 1987.
Semmler W, Gademann G, Bachert-Baumann P et al: Monitoring human tumor response to therapy by means of P-31 MR spectroscopy. Radiology 166:533–539, 1988.
Negeodank WG, Crowley MG, Ryan JR et al: Combined 1H MRI and 31P MRS for diagnosis of bone and soft tissue lesions. Radiology 173:181–188, 1989.
Brown TR, Kincaid BM, Ugurbil K: NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA 79:3523–3526, 1982.
Ordidge RJ, Connelly A, Lohman JAB: Imaging-selected in vivo spectroscopy (ISIS): A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 66:283–294, 1987.
Maris JM, Evans AE, McLaughlin AC et al: 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. New England J. Med. 312:1500–1505, 1985.
Segebarth CM, Baleriaux DF, Arnold DL et al: MR image-guided P-31 spectroscopy in the evaluation of brain tumor treatment. Radiology 165:215–219, 1987.
Evelhoch JL, Keller NA, Corbett TH: Response-specific adria-mycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Cancer Res. 47:3396–3401, 1987.
Karczmar GS, Poole J, Boska MD et al: 31P MRS study of response of human tumors to therapy. Soc. Magn. Reson. Med. (Abst. 615), 1988.
Glaholm J, Sharp JC, Collins D et al: In vivo localized 31P spectroscopy of human breast carcinoma. Soc. Magn. Reson. Med. (Abst. 165), 1988.
Ng TC, Grundfest S, Vijayakumar S et al: Therapeutic response of breast carcinoma monitored by 31P MRS in situ. Magn. Reson. Med. 10:125–134, 1989.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Negendank, W.G., Crowley, M.G., Ryan, J.R., Keller, N.A., Evelhoch, J.L. (1990). Combined MRI and 31P MRS for Diagnosis of Bone and Soft Tissue Lesions. In: Evelhoch, J.L., Negendank, W., Valeriote, F.A., Baker, L.H. (eds) Magnetic Resonance in Experimental and Clinical Oncology. Developments in Oncology, vol 61. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0691-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0691-7_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8028-6
Online ISBN: 978-1-4613-0691-7
eBook Packages: Springer Book Archive